According to molecular subtype, breast cancer is divided into Luminal A, Luminal B, HER2-enriched, and triple-negative subtypes, among which the luminal subtype, accounting for 65% to 70% of the cases, has the highest proportion (3). Here, ERBB2 is linked to breast cancer.